| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.89B | -2.5% |
| Cost of Revenue | $1.78B | -2.9% |
| Gross Profit | $1.10B | -1.8% |
| R&D Expense | $31.6M | -4.0% |
| SG&A Expense | $526.3M | +7.5% |
| Interest Expense | $155.7M | -7.7% |
| Pre-tax Income | $53.8M | -69.4% |
| Income Tax | $15.7M | -55.4% |
| Net Income | $38.1M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $216.9M | -2.9% |
| Accounts Receivable | $441.3M | -13.7% |
| Inventory | $657.3M | +1.2% |
| Current Assets | $1.48B | -5.0% |
| Total Assets | $4.34B | -3.7% |
| Current Liabilities | $819.8M | +11.7% |
| Long-term Debt | $3.23B | -4.3% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $429.6M | +8.7% |
| Capital Expenditures | $97.9M | +72.4% |
| Investing Cash Flow | -$114.0M | -103.2% |
| Financing Cash Flow | -$300.3M | +2.9% |
| Free Cash Flow | $331.7M | -2.0% |
| -72.9% |
| EPS (Basic) | $0.53 | -73.1% |
| EPS (Diluted) | $0.52 | -73.2% |
| Total Liabilities |
| $4.21B |
| -2.1% |
| Stockholders' Equity | $135.8M | -35.5% |